The use of infliximab in the prevention of postsurgical recurrence in polysurgery Crohn's disease patients: A pilot open-labeled prospective study

International Journal of Colorectal Disease

Volumn 27, Issue 7, 2012, Pages 947-952

  Sakuraba, Atsushi ^a,b   Sato, Toshiro ^a   Matsukawa, Hidehiko ^c   Okamoto, Susumu ^a   Takaishi, Hiromasa ^a   Ogata, Haruhiko ^a   Iwao, Yasushi ^a   Hibi, Toshifumi ^a  

^a Institute for Advanced Medical Research   (Japan)

^b KITASATO INSTITUTE HOSPITAL   (Japan)

^c Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

Author keywords

Crohn's disease; Infliximab; Maintenance; Postsurgical recurrence

Indexed keywords

CHLORPHENIRAMINE; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; PARACETAMOL; STEROID; VALACICLOVIR;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON SURGERY; COLONOSCOPY; CROHN DISEASE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG INFUSION REACTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EARLY INTERVENTION; FEMALE; HERPES ZOSTER; HIGH RISK PATIENT; HUMAN; INFECTION; INTESTINE RADIOGRAPHY; MALE; MALIGNANT NEOPLASTIC DISEASE; OPEN STUDY; OUTCOME ASSESSMENT; PILOT STUDY; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; REMISSION; RISK BENEFIT ANALYSIS; TREATMENT DURATION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84864457761     PISSN: 01791958     EISSN: 14321262     Source Type: Journal    
DOI: 10.1007/s00384-011-1398-y     Document Type: Article

References (17)

1. Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(Suppl 1):S3-S9
2. OK Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-434
3. OK Hibi T, Ogata H (2006) Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 41:10-16
4. OK Sakuraba A, Sato T, Kamada N, Kitazume M, Sugita A, Hibi T (2009) Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 137:1736-1745
5. OK Hanauer SB (1996) Inflammatory bowel disease. N Engl J Med 334:841-848
6. Rutgeerts P, Geboes K, Vantrappen G, Beyls J, Kerremans R, Hiele M (1990) Predictability of the postoperative course of Crohn's disease. Gastroenterology 99:956-963
7. Michelassi F, Balestracci T, Chappell R, Block GE (1991) Primary and recurrent Crohn's disease. Experience with 1379 patients. Ann Surg 214:230-238, Discussion 238-240
8. OK Sutherland LR, Ramcharan S, Bryant H, Fick G (1990) Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 98:1123-1128
9. OK Mekhjian HS, Switz DM,Watts HD, Deren JJ, Katon RM, Beman FM (1979) National Cooperative Crohn's Disease Study: factors determining recurrence of Crohn's disease after surgery. Gastroenterology 77:907-913
10. OK Hanauer SB, Present DH (2003) The state of the art in the management of inflammatory bowel disease. Rev Gastroenterol Disord 3:81-92
11. Hanauer SB (2004) Review article: aminosalicylates in inflammatory bowel disease. Aliment Pharmacol Ther 20(Suppl 4):60-65
12. OK Guessous I, Juillerat P, Pittet V, Froehlich F, Burnand B, Mottet C, Felley C, Michetti P, Vader JP (2007) Evaluating appropriateness of treatment for Crohn's disease: feasibility of an explicit approach. Digestion 75:46-52
13. Rutgeerts P, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Hanauer SB (2004) Comparison of scheduled and episodic treatment strategies of infliximab in Crohn's disease. Gastroenterology 126:402-413
14. Regueiro M, Schraut W, Baidoo L, Kip KE, Sepulveda AR, Pesci M, Harrison J, Plevy SE (2009) Infliximab prevents Crohn's disease recurrence after ileal resection. Gastroenterology 136:441-450, e1; quiz 716
15. OK Yamamoto T, Umegae S, Matsumoto K (2009) Impact of infliximab therapy after early endoscopic recurrence following ileocolonic resection of Crohn's disease: a prospective pilot study. Inflamm Bowel Dis 15:1460-1466
16. OK Komiyama T, Yajima T, Kubota R, Iwao Y, Sakuraba A, Funakoshi S, Negishi K, Minami I, Tanaka Y, Mae H (2008) Lower doses of 6-mercaptopurine/ azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6- mercaptopurinemetabolite in Japanese IBDpatients. J Crohns Colitis 2:315-321
17. OK Sorrentino D, Terrosu G, Avellini C, Maiero S (2007) Infliximab with low-dose methotrexate for prevention of postsurgical recurrence of ileocolonic Crohn disease. Arch Intern Med 167:1804-1807